Porter W Anderson Jr.

Global Genetic Diagnostics Market Report 2023: Rising Number of Genetic Disorders Stimulates Growth - ResearchAndMarkets.com

Retrieved on: 
Monday, January 9, 2023
Health, Genetics, Disease, Genetic testing, International System for Human Cytogenetic Nomenclature, Prenatal development, QIAGEN, Cancer, Parent, Porter W Anderson Jr., Government, Porter's five forces analysis, Thermo Fisher Scientific, Competition, Cytogenetics, Illumina, Inc., Organization, Growth, Abbott Laboratories, Patient, SWOT, Mortality, Quest Diagnostics, Myriad Genetics, Hoffmann-La Roche, USD, Genetic disorder, COVID-19, Danaher Corporation, Pharmaceutical industry, Medical device, Application

The genetic diagnostics market is driven by a rising number of genetic disorder cases.

Key Points: 
  • The genetic diagnostics market is driven by a rising number of genetic disorder cases.
  • The report analyses the Genetic Diagnostics Market By Type (Predictive and Presymptomatic Testing, Diagnostics Testing, Prenatal and Newborn Testing, Pharmacogenetic Testing, Other Application).
  • The report analyses the Genetic Diagnostics Market By Application (Cancer Diagnosis, Genetic Disease Diagnosis, Cardiovascular Disease Diagnosis, Other Application).
  • The Global Genetic Diagnostics Market has been analysed by countries (United States, Canada, Germany, UK, France, Spain, China, Japan, India, Australia).

Global Respiratory Disease Vaccine Market Report 2022: Increasing R&D Expenditure by Leading Companies Presents Opportunities - ResearchAndMarkets.com

Retrieved on: 
Friday, November 4, 2022
Health, Infectious Diseases, Other Health, COVID-19, Pharmaceutical, Biotechnology, Adolescence, Geography, Profile, Inactivated vaccine, Whooping cough, Porter W Anderson Jr., Vaccination, CAGR, Industry, Adult, Streptococcus pneumoniae, Global, COVID-19, USD, Infection, Infant, Observation, Ansoff Matrix, Vaccine, Pharmaceutical industry, Tuberculosis

The Global Respiratory Disease Vaccine Market is estimated to be USD 22.16 Bn in 2022 and is expected to reach USD 29.71 Bn by 2027, growing at a CAGR of 6.04%.

Key Points: 
  • The Global Respiratory Disease Vaccine Market is estimated to be USD 22.16 Bn in 2022 and is expected to reach USD 29.71 Bn by 2027, growing at a CAGR of 6.04%.
  • The Global Respiratory Disease Vaccine Market is segmented based on Infection, Type, Age Group, and Geography.
  • By Type, the market is classified into Bacterial Vaccine, Combination Vaccine, and Viral Vaccine.
  • The report offers a comprehensive evaluation of the Global Respiratory Disease Vaccine Market.

The Worldwide H1N1 Vaccines Industry is Expected to Reach $4.6 Billion by 2027 - ResearchAndMarkets.com

Retrieved on: 
Friday, May 13, 2022
Infectious Diseases, Biotechnology, Pharmaceutical, Health, SWOT, National Center for Immunization and Respiratory Diseases, Risk, Consultant, Bronchitis, Porter W Anderson Jr., Patient, COPD, Vaccine, NIP, COVID-19, Influenza A virus subtype H1N1, Research, United Kingdom, Industry, Infection, Awareness, Chronic obstructive pulmonary disease, Immunity, Headache, CAGR, Aquaculture, Pharmaceutical industry, H1N1, Growth, Pneumonia

The "H1N1 Vaccines Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "H1N1 Vaccines Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027" report has been added to ResearchAndMarkets.com's offering.
  • The global H1N1 vaccines market reached a value of US$ 3.4 billion in 2021.
  • Looking forward, the market is projected to reach US$ 4.6 billion by 2027, exhibiting at a CAGR of 5.4 % during 2022-2027.
  • How has the global H1N1 vaccines market performed so far and how will it perform in the coming years?

23 Valent Pneumococcal Polysaccharide Vaccine Market Research Report 2022 - ResearchAndMarkets.com

Retrieved on: 
Monday, March 14, 2022
Medical Supplies, Health, Row, CAGR, Porter W Anderson Jr., Matrix, Vaccine, Aquaculture

The "23 Valent Pneumococcal Polysaccharide Vaccine Market: Global Industry Analysis, Trends, Market Size, and Forecasts up to 2027" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "23 Valent Pneumococcal Polysaccharide Vaccine Market: Global Industry Analysis, Trends, Market Size, and Forecasts up to 2027" report has been added to ResearchAndMarkets.com's offering.
  • The report predicts the global 23 valent pneumococcal polysaccharide vaccine market to grow with a CAGR of 9% over the forecast period from 2021-2027.
  • The report on the global 23 valent pneumococcal polysaccharide vaccine market provides qualitative and quantitative analysis for the period from 2019 to 2027.
  • The report on 23 valent pneumococcal polysaccharide vaccine market is a comprehensive study and presentation of drivers, restraints, opportunities, demand factors, market size, forecasts, and trends in the global 23 valent pneumococcal polysaccharide vaccine market over the period of 2019 to 2027.